The near-term default risk is deferred, but the 10% penalty and deeply discounted conversion option create a toxic financing structure. Expect heavy selling pressure as Lind converts shares at a discount and flips them. Monitor the next 10-Q for the full waiver text and any further covenant breaches. The stock is likely to trade down on this news.
Price Chart
Executive Summary
VolitionRx disclosed it violated the minimum market capitalization covenant on its $9.9M in aggregate senior secured convertible notes held by Lind Global Asset Management. Lind waived its rights to accelerate or foreclose on the notes but imposed a 10% penalty on the outstanding principal and secured a more favorable conversion price (90% of the three lowest VWAPs over 20 days). This avoids immediate default but signals severe financial distress and creates heavy future dilution risk.
Key Facts
- VolitionRx failed to maintain the minimum market capitalization covenant on its $7.5M (May 2025) and $2.4M (Jan 2026) senior secured convertible notes held by Lind Global Asset Management.
- Lind waived rights to accelerate, demand payment, or foreclose on collateral due to the covenant breach, but the waiver is conditional and preserves certain conversion rights.
- A 10% penalty on the outstanding principal of each note was triggered by the covenant failure.
- Lind can now convert at the lower of the current conversion price or 90% of the average of the three lowest VWAPs over the 20 trading days before conversion, subject to a 4.99% beneficial ownership cap.
- The waiver was executed on May 21, 2026, just 7 days after a board member (Mickie Henshall) decided not to stand for re-election, suggesting governance instability.
Financial Impact
10% penalty on $9.9M total principal = $990,000 additional liability; conversion at a deep discount to market price will cause significant dilution to existing shareholders.
Risk Factors
- Further market cap decline could trigger additional covenant breaches or force a restructuring.
- Lind's conversion at a 10%+ discount to VWAP will dilute existing shareholders and pressure the stock price.
- The departure of a board member within 7 days of this filing suggests potential governance or strategic disagreements.
- The company may need to raise additional capital on unfavorable terms, further diluting equity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-003416 |
| Document: 0001477932-26-003416-index-headers.html | 0001477932-26-003416 |
| Document: 0001477932-26-003416-index.html | 0001477932-26-003416 |
| Document: 0001477932-26-003416.txt | 0001477932-26-003416 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.1900 | awaiting T+60 | — | $0.1900 (−0.00%) |
Sep 25, 2026 4w ago | 8-K | $0.2529 | awaiting T+60 | — | $0.1900 (+24.87%) |
Sep 16, 2026 5w ago | SC 13D/A | $0.2849 | awaiting T+60 | — | $0.1900 (−33.31%) |
Sep 15, 2026 6w ago | 8-K | $0.2749 | awaiting T+60 | — | $0.1900 (+30.88%) |
Sep 11, 2026 6w ago | EFFECT | $0.3102 | awaiting T+60 | — | $0.1900 (+38.75%) |
Sep 8, 2026 7w ago | S-3/A | $0.3400 | awaiting T+60 | — | $0.1900 (+44.12%) |
Sep 1, 2026 7w ago | 8-K | $0.3800 | awaiting T+60 | — | $0.1900 (+50.00%) |
Aug 24, 2026 9w ago | 8-K | $0.3846 | awaiting T+60 | — | $0.1900 (+50.60%) |
Aug 7, 2026 11w ago | 8-K | $0.7700 | awaiting T+60 | — | $0.1900 (+75.32%) |
Jul 20, 2026 14w ago | EFFECT | $1.13 $0.1847 | ▲ +83.65% | ▲ +88.50% | $0.1900 (+83.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers